JOONGKYEOM ANTIBODY THERAPY

Serial Number 79333375
Registration 7014770
700

Registration Progress

Application Filed
Nov 16, 2021
Under Examination
Approved for Publication
Jan 17, 2023
Published for Opposition
Jan 17, 2023
Registered
Apr 4, 2023

Trademark Image

JOONGKYEOM ANTIBODY THERAPY

Basic Information

Serial Number
79333375
Registration Number
7014770
Filing Date
November 16, 2021
Registration Date
April 4, 2023
Published for Opposition
January 17, 2023
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Apr 4, 2023
Registration
Registered
Classes
042

Rights Holder

JOONGKYEOM Co., Ltd.

03
Address
529, Seonghyeon-ro,
Ilsandong-gu, Goyang-si Gyeonggi-do 1026
KR

Ownership History

JOONGKYEOM Co., Ltd.

Original Applicant
03
KR

JOONGKYEOM Co., Ltd.

Owner at Publication
03
KR

JOONGKYEOM Co., Ltd.

Original Registrant
03
KR

Legal Representation

Attorney
Ziwen Zhu

USPTO Deadlines

Next Deadline
1196 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20230404)
Due Date
April 04, 2029
Grace Period Ends
October 04, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

29 events
Date Code Type Description Documents
May 11, 2024 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Aug 14, 2023 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Jul 24, 2023 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Jul 24, 2023 FIMP P FINAL DISPOSITION PROCESSED Loading...
Jul 4, 2023 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Apr 4, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Apr 4, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 25, 2023 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Jan 17, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 17, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 4, 2023 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Jan 4, 2023 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Dec 28, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 15, 2022 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 14, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 13, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 13, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 14, 2022 RFNP P REFUSAL PROCESSED BY IB Loading...
Oct 22, 2022 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Oct 21, 2022 RFRR P REFUSAL PROCESSED BY MPU Loading...
Aug 31, 2022 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Aug 30, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 30, 2022 RFWR P NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW Loading...
Aug 28, 2022 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Aug 27, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 27, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 19, 2022 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Feb 15, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 10, 2022 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 042
Research and development of vaccines and medicines; advisory services relating to biotechnology; research relating to biotechnology; consulting services in the fields of biotechnology; biological research; medical research in the field of crude drugs; biochemical analysis; biochemistry research services; research on adult diseases; research relating to bacteriology; research services in the fields of cancerous diseases; development of pharmaceuticals; research relating to pharmaceuticals; advisory services relating to development of pharmaceuticals; pharmaceutical products evaluation; consultancy pertaining to pharmacology; research in the field of gene analysis; genetic research; research relating to medical products; medical research services

Additional Information

Design Mark
The mark consists of the wording "JOONGKYEOM" stacked above the wording "ANTIBODY THERAPY", wherein an infinity symbol represents the letters "OO", all to the left of a stylized letter "X" and its shadow.

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"ANTIBODY THERAPY"